{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:52:51Z","timestamp":1781776371777,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Natural Science Foundation of China-Youth Foundation","award":["NO.82102058"],"award-info":[{"award-number":["NO.82102058"]}]},{"name":"Jiangsu Government Scholarship for Overseas Studies in 2024"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"DOI":"10.1007\/s11010-026-05543-9","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T08:51:49Z","timestamp":1778662309000},"page":"2481-2495","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dose- and time-dependent cardioprotection of liproxstatin-1 via sequential modulation of ferroptosis pathways after myocardial ischemia-reperfusion"],"prefix":"10.1007","volume":"481","author":[{"given":"Ziwei","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"8","key":"5543_CR1","doi-asserted-by":"publisher","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI et al (2022) Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation 145(8):e153\u2013e639. https:\/\/doi.org\/10.1161\/CIR.0000000000001052","journal-title":"Circulation"},{"issue":"12","key":"5543_CR2","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41569-020-0403-y","volume":"17","author":"G Heusch","year":"2020","unstructured":"Heusch G (2020) Myocardial ischaemia-reperfusion injury and cardioprotection in perspective. Nat Rev Cardiol 17(12):773\u2013789. https:\/\/doi.org\/10.1038\/s41569-020-0403-y","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"5543_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.medj.2023.12.007","volume":"5","author":"G Heusch","year":"2024","unstructured":"Heusch G (2024) Myocardial ischemia\/reperfusion: translational pathophysiology of ischemic heart disease. Med N Y N 5(1):10\u201331. https:\/\/doi.org\/10.1016\/j.medj.2023.12.007","journal-title":"Med N Y N"},{"issue":"2","key":"5543_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020897","volume":"25","author":"VV Ryabov","year":"2024","unstructured":"Ryabov VV, Maslov LN, Vyshlov EV et al (2024) Ferroptosis, a regulated form of cell death, as a target for the development of novel drugs preventing ischemia\/reperfusion of cardiac injury, cardiomyopathy and stress-induced cardiac injury. Int J Mol Sci 25(2):897. https:\/\/doi.org\/10.3390\/ijms25020897","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5543_CR5","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"issue":"9","key":"5543_CR6","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.bbagen.2019.06.010","volume":"1863","author":"T Nakamura","year":"2019","unstructured":"Nakamura T, Naguro I, Ichijo H (2019) Iron homeostasis and iron-regulated ROS in cell death, senescence and human diseases. Biochim Biophys Acta Gen Subj 1863(9):1398\u20131409. https:\/\/doi.org\/10.1016\/j.bbagen.2019.06.010","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"10","key":"5543_CR7","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1016\/j.apsb.2020.07.003","volume":"10","author":"A Alu","year":"2020","unstructured":"Alu A, Han X, Ma X, Wu M, Wei Y, Wei X (2020) The role of lysosome in regulated necrosis. Acta Pharm Sin B 10(10):1880\u20131903. https:\/\/doi.org\/10.1016\/j.apsb.2020.07.003","journal-title":"Acta Pharm Sin B"},{"issue":"7","key":"5543_CR8","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang X, Wang H, Han D et al (2019) Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A 116(7):2672\u20132680. https:\/\/doi.org\/10.1073\/pnas.1821022116","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5543_CR9","unstructured":"9. Recent advances in the interaction of ferroptosis and immune-mediated inflammation in cardiovascular disease: mechanisms and therapeutic potential - PubMed. Accessed March 10, 2026. https:\/\/pubmed.ncbi.nlm.nih.gov\/41394800\/"},{"issue":"7","key":"5543_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12071396","volume":"12","author":"P Pagliaro","year":"2023","unstructured":"Pagliaro P, Penna C (2023) Inhibitors of NLRP3 inflammasome in ischemic heart disease: focus on functional and redox aspects. Antioxidants 12(7):1396. https:\/\/doi.org\/10.3390\/antiox12071396","journal-title":"Antioxidants"},{"key":"5543_CR11","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q (2013) Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol 53:401\u2013426. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140320","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"6","key":"5543_CR12","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.tips.2013.04.005","volume":"34","author":"T Suzuki","year":"2013","unstructured":"Suzuki T, Motohashi H, Yamamoto M (2013) Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 34(6):340\u2013346. https:\/\/doi.org\/10.1016\/j.tips.2013.04.005","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"5543_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/13880209.2021.2007269","volume":"60","author":"H Lu","year":"2022","unstructured":"Lu H, Xiao H, Dai M, Xue Y, Zhao R (2022) Britanin relieves ferroptosis-mediated myocardial ischaemia\/reperfusion damage by upregulating GPX4 through activation of AMPK\/GSK3\u03b2\/Nrf2 signalling. Pharm Biol 60(1):38\u201345. https:\/\/doi.org\/10.1080\/13880209.2021.2007269","journal-title":"Pharm Biol"},{"issue":"2","key":"5543_CR14","doi-asserted-by":"publisher","first-page":"10924","DOI":"10.1080\/21655979.2021.1995994","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu S, Wu B, Zhong B et al (2021) Naringenin alleviates myocardial ischemia\/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) \/system xc-\/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered 12(2):10924\u201310934. https:\/\/doi.org\/10.1080\/21655979.2021.1995994","journal-title":"Bioengineered"},{"issue":"19","key":"5543_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20194968","volume":"20","author":"N Kajarabille","year":"2019","unstructured":"Kajarabille N, Latunde-Dada GO (2019) Programmed cell-death by ferroptosis: antioxidants as mitigators. Int J Mol Sci 20(19):4968. https:\/\/doi.org\/10.3390\/ijms20194968","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5543_CR16","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.bbrc.2019.10.006","volume":"520","author":"Y Feng","year":"2019","unstructured":"Feng Y, Madungwe NB, Imam Aliagan AD, Tombo N, Bopassa JC (2019) Liproxstatin-1 protects the mouse myocardium against ischemia\/reperfusion injury by decreasing VDAC1 levels and restoring GPX4 levels. Biochem Biophys Res Commun 520(3):606\u2013611. https:\/\/doi.org\/10.1016\/j.bbrc.2019.10.006","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"5543_CR17","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B et al (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16(12):1180\u20131191. https:\/\/doi.org\/10.1038\/ncb3064","journal-title":"Nat Cell Biol"},{"issue":"3","key":"5543_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.4103\/1673-5374.293157","volume":"16","author":"BY Fan","year":"2021","unstructured":"Fan BY, Pang YL, Li WX et al (2021) Liproxstatin-1 is an effective inhibitor of oligodendrocyte ferroptosis induced by inhibition of glutathione peroxidase 4. Neural Regen Res 16(3):561\u2013566. https:\/\/doi.org\/10.4103\/1673-5374.293157","journal-title":"Neural Regen Res"},{"issue":"3","key":"5543_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka O, Shah R, Li B et al (2017) On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci 3(3):232\u2013243. https:\/\/doi.org\/10.1021\/acscentsci.7b00028","journal-title":"ACS Cent Sci"},{"key":"5543_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070879","author":"S X","year":"2024","unstructured":"X S, F L, Y Z et al (2024) Radiation-induced endothelial ferroptosis accelerates atherosclerosis via the DDHD2-mediated Nrf2\/GPX4 pathway. Biomolecules. https:\/\/doi.org\/10.3390\/biom14070879","journal-title":"Biomolecules"},{"key":"5543_CR21","doi-asserted-by":"crossref","unstructured":"21. Z W, M H, J D, et al. Nrf2 attenuates diquat-induced renal ferroptosis by regulating mitochondrial ferritin. Toxicol Mech Methods. Published online June 3, 2026. doi:10.1080\/15376516.2026.2641204","DOI":"10.1080\/15376516.2026.2641204"},{"issue":"5","key":"5543_CR22","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.molcel.2020.10.010","volume":"80","author":"N Takahashi","year":"2020","unstructured":"Takahashi N, Cho P, Selfors LM et al (2020) 3D culture models with CRISPR screens reveal hyperactive NRF2 as a prerequisite for spheroid formation via regulation of proliferation and ferroptosis. Mol Cell 80(5):828-844.e6. https:\/\/doi.org\/10.1016\/j.molcel.2020.10.010","journal-title":"Mol Cell"},{"issue":"1","key":"5543_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24010449","volume":"24","author":"L Rochette","year":"2022","unstructured":"Rochette L, Dogon G, Rigal E, Zeller M, Cottin Y, Vergely C (2022) Lipid peroxidation and iron metabolism: two corner stones in the homeostasis control of ferroptosis. Int J Mol Sci 24(1):449. https:\/\/doi.org\/10.3390\/ijms24010449","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5543_CR24","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA (2024) The cell biology of ferroptosis. Nat Rev Mol Cell Biol 25(6):424\u2013442. https:\/\/doi.org\/10.1038\/s41580-024-00703-5","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"5543_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.ade9585","volume":"9","author":"A Anandhan","year":"2023","unstructured":"Anandhan A, Dodson M, Shakya A et al (2023) NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8. Sci Adv 9(5):eade9585. https:\/\/doi.org\/10.1126\/sciadv.ade9585","journal-title":"Sci Adv"},{"key":"5543_CR26","doi-asserted-by":"crossref","unstructured":"26. Rodriguez R, Ca\u00f1eque T, Baron L, et al. Activation of lysosomal iron triggers ferroptosis in cancer. Res Sq. Published online April 8, 2024:rs.3.rs-4165774. doi:10.21203\/rs.3.rs-4165774\/v1","DOI":"10.21203\/rs.3.rs-4165774\/v1"},{"key":"5543_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58909-w","volume":"16","author":"Y Saimoto","year":"2025","unstructured":"Saimoto Y, Kusakabe D, Morimoto K et al (2025) Lysosomal lipid peroxidation contributes to ferroptosis induction via lysosomal membrane permeabilization. Nat Commun 16:3554. https:\/\/doi.org\/10.1038\/s41467-025-58909-w","journal-title":"Nat Commun"},{"issue":"18","key":"5543_CR28","doi-asserted-by":"publisher","first-page":"3347","DOI":"10.1016\/j.molcel.2023.08.004","volume":"83","author":"RV Swanda","year":"2023","unstructured":"Swanda RV, Ji Q, Wu X et al (2023) Lysosomal cystine governs ferroptosis sensitivity in cancer via cysteine stress response. Mol Cell 83(18):3347-3359.e9. https:\/\/doi.org\/10.1016\/j.molcel.2023.08.004","journal-title":"Mol Cell"},{"issue":"6","key":"5543_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.62347\/OLGV6926","volume":"15","author":"YL Wei","year":"2025","unstructured":"Wei YL, Cheng L, Chen XY et al (2025) Ferroptosis in ischemia-reperfusion injury: molecular mechanisms and therapeutic strategies. Am J Cardiovasc Dis 15(6):405\u2013441. https:\/\/doi.org\/10.62347\/OLGV6926","journal-title":"Am J Cardiovasc Dis"},{"issue":"1","key":"5543_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02851-6","volume":"30","author":"T Zhang","year":"2025","unstructured":"Zhang T, Han Y, Wang Y et al (2025) The interaction between ferroptosis and myocardial ischemia-reperfusion injury: molecular mechanisms and potential therapeutic targets. Eur J Med Res 30(1):643. https:\/\/doi.org\/10.1186\/s40001-025-02851-6","journal-title":"Eur J Med Res"},{"issue":"2","key":"5543_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s11010-025-05440-7","volume":"481","author":"Y Xu","year":"2026","unstructured":"Xu Y, Wu S, Zhang L, Zhang M, Jiang Y (2026) Cell death forms in myocardial ischemia-reperfusion injury and their potential clinical applications. Mol Cell Biochem 481(2):695\u2013709. https:\/\/doi.org\/10.1007\/s11010-025-05440-7","journal-title":"Mol Cell Biochem"},{"issue":"11\u201312","key":"5543_CR32","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1007\/s10495-025-02192-z","volume":"30","author":"Y Li","year":"2025","unstructured":"Li Y, Lou Z, Liu F et al (2025) The impact of lipid metabolism on ferroptosis in myocardial ischemia-reperfusion injury. Apoptosis 30(11\u201312):2761\u20132775. https:\/\/doi.org\/10.1007\/s10495-025-02192-z","journal-title":"Apoptosis"},{"issue":"1","key":"5543_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02372-5","volume":"11","author":"B Du","year":"2025","unstructured":"Du B, Fu Q, Yang Q et al (2025) Different types of cell death and their interactions in myocardial ischemia-reperfusion injury. Cell Death Discov 11(1):87. https:\/\/doi.org\/10.1038\/s41420-025-02372-5","journal-title":"Cell Death Discov"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-026-05543-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-026-05543-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T09:06:12Z","timestamp":1781773572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-026-05543-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["5543"],"URL":"https:\/\/doi.org\/10.1007\/s11010-026-05543-9","relation":{},"ISSN":["1573-4919"],"issn-type":[{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"17 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Nanjing First Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}